• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的稳定期患者复杂肺部疾病的自然史。

Natural history of complex lung disease in untreated patients with stable course.

机构信息

Dept of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

These authors contributed equally to this work.

出版信息

Eur Respir J. 2017 Mar 8;49(3). doi: 10.1183/13993003.00537-2016. Print 2017 Mar.

DOI:10.1183/13993003.00537-2016
PMID:28275170
Abstract

Little is known about the long-term natural history of complex lung disease (MAC-LD) in untreated patients with stable course.The aim of this study was to investigate the natural course of untreated stable MAC-LD, with a focus on factors associated with clinical deterioration, spontaneous sputum conversion and prognosis.Of 488 patients diagnosed with MAC-LD between 1998 and 2011, 305 patients (62.5%) showed progressive MAC-LD resulting in treatment initiation within 3 years of diagnosis and 115 patients (23.6%) exhibited stable MAC-LD for at least 3 years with a median follow-up duration of 5.6 years. Patients with stable MAC-LD were more likely to have higher body mass index and less systemic symptoms at initial diagnosis compared with patients with progressive MAC-LD, while positive sputum acid-fast bacilli smear, fibrocavitary type and more extensive disease in radiological findings were more associated with progressive MAC-LD. Of the untreated patients with stable MAC-LD, 51.6% underwent spontaneous sputum conversion, with younger age, higher body mass index and negative sputum acid-fast bacilli smear at initial diagnosis found to be predictors of this occurrence.Advanced age, fibrocavitary type and abnormal pulmonary function were negative prognostic factors for survival in patients with stable MAC-LD.

摘要

对于未经治疗且病情稳定的复杂肺部疾病(MAC-LD)患者,其长期自然病史知之甚少。本研究旨在探讨未经治疗的稳定 MAC-LD 的自然病程,重点关注与临床恶化、自发痰转化和预后相关的因素。在 1998 年至 2011 年间诊断为 MAC-LD 的 488 例患者中,305 例(62.5%)出现进行性 MAC-LD,导致在诊断后 3 年内开始治疗,115 例(23.6%)至少稳定 MAC-LD 3 年,中位随访时间为 5.6 年。与进行性 MAC-LD 患者相比,稳定 MAC-LD 患者在初始诊断时更可能具有更高的体重指数和较少的全身症状,而阳性痰抗酸杆菌涂片、纤维空洞型和影像学检查中更广泛的病变与进行性 MAC-LD 更相关。在未经治疗的稳定 MAC-LD 患者中,51.6%自发痰转化,初始诊断时年龄较小、体重指数较高和痰抗酸杆菌涂片阴性是自发痰转化的预测因素。高龄、纤维空洞型和肺功能异常是稳定 MAC-LD 患者生存的负性预后因素。

相似文献

1
Natural history of complex lung disease in untreated patients with stable course.未经治疗的稳定期患者复杂肺部疾病的自然史。
Eur Respir J. 2017 Mar 8;49(3). doi: 10.1183/13993003.00537-2016. Print 2017 Mar.
2
Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.对782例结节性/支气管扩张型鸟分枝杆菌复合群肺病患者的死亡率和影像学恶化预测因素的回顾性研究。
BMJ Open. 2015 Aug 5;5(8):e008058. doi: 10.1136/bmjopen-2015-008058.
3
The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.非空洞性结节状支气管扩张分枝杆菌复合体肺病的自然病史。
Respir Med. 2019 Apr;150:45-50. doi: 10.1016/j.rmed.2019.02.007. Epub 2019 Feb 12.
4
Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.影响鸟分枝杆菌复合群肺病患者痰菌转阴及治疗结果的因素。
J Microbiol Immunol Infect. 2007 Aug;40(4):342-8.
5
Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.分枝杆菌复合群肺病患者的微生物持续存在:预测因素及其对影像学进展的影响。
Clin Infect Dis. 2017 Sep 15;65(6):927-934. doi: 10.1093/cid/cix479.
6
Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病成功治疗后复发的决定因素。
Int J Tuberc Lung Dis. 2015 Oct;19(10):1239-45. doi: 10.5588/ijtld.14.0139.
7
Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.大环内酯类耐药与难治性鸟分枝杆菌复合群肺病再感染的发生
Am J Respir Crit Care Med. 2018 Nov 15;198(10):1322-1330. doi: 10.1164/rccm.201802-0321OC.
8
Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease.非空洞性结节状支气管扩张性鸟分枝杆菌复合群肺病患者痰菌阴转后的再发情况。
J Infect Chemother. 2021 Aug;27(8):1156-1161. doi: 10.1016/j.jiac.2021.03.006. Epub 2021 Mar 18.
9
Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease.不同亚种对初治的鸟分枝杆菌复合体肺病患者疾病进展的影响。
Clin Microbiol Infect. 2021 Mar;27(3):467.e9-467.e14. doi: 10.1016/j.cmi.2020.04.020. Epub 2020 Apr 28.
10
Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.鸟分枝杆菌复合群肺病:HIV 阴性患者的治疗选择
J La State Med Soc. 2008 Sep-Oct;160(5):248-54; quiz 254, 293.

引用本文的文献

1
Environmental intervention for two cases of non-tuberculous mycobacterial disease.两例非结核分枝杆菌病的环境干预措施
Nagoya J Med Sci. 2025 May;87(2):351-359. doi: 10.18999/nagjms.87.2.351.
2
Current and emerging treatment strategies for complex pulmonary disease: a narrative review.复杂肺部疾病的当前及新出现的治疗策略:一篇叙述性综述
Ewha Med J. 2025 Apr;48(2):e25. doi: 10.12771/emj.2025.00080. Epub 2025 Mar 26.
3
Clinical Outcomes of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-cell Therapy in Patients With Antecedent Complex Pulmonary Disease: A Case Series of 8 Patients.
既往患有复杂肺部疾病患者的造血细胞移植和嵌合抗原受体T细胞疗法的临床结局:8例病例系列研究
Open Forum Infect Dis. 2025 May 2;12(5):ofaf268. doi: 10.1093/ofid/ofaf268. eCollection 2025 May.
4
Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study.治疗难治性复杂性肺部疾病的预测风险因素:一项单中心回顾性队列研究。
Ther Adv Infect Dis. 2025 Apr 11;12:20499361251331676. doi: 10.1177/20499361251331676. eCollection 2025 Jan-Dec.
5
Trial Conduct, Baseline Characteristics, and Symptom Burden of Patients in the ARISE Study.ARISE研究中患者的试验实施、基线特征及症状负担
Pulm Ther. 2025 Jun;11(2):269-283. doi: 10.1007/s41030-025-00293-3. Epub 2025 Apr 8.
6
Differences in sputum microbiota based on cure status of patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者痰液微生物群基于治愈状态的差异。
Korean J Intern Med. 2025 May;40(3):449-457. doi: 10.3904/kjim.2024.209. Epub 2025 Mar 25.
7
Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis.患有囊性纤维化和非囊性纤维化支气管扩张症的女性中的肺部非结核分枝杆菌感染。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251323181. doi: 10.1177/17534666251323181. Epub 2025 Mar 12.
8
Comprehensive Management Algorithm for Complex Pulmonary Disease in the Real-World Setting.真实世界中复杂肺部疾病的综合管理算法
Ann Am Thorac Soc. 2025 May;22(5):651-659. doi: 10.1513/AnnalsATS.202408-904FR.
9
Bibliometric Analysis of Nontuberculous Mycobacteria Research in South Korea.韩国非结核分枝杆菌研究的文献计量分析
Tuberc Respir Dis (Seoul). 2025 Apr;88(2):353-360. doi: 10.4046/trd.2024.0158. Epub 2025 Jan 14.
10
A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom.英国疑似非结核分枝杆菌肺病(NTM-PD)诊断与管理实用指南
NPJ Prim Care Respir Med. 2024 Dec 21;34(1):45. doi: 10.1038/s41533-024-00403-9.